Specializing in complex injectables, oral solids, oral liquids, and sterile ophthalmics — with fee-for-service and co-development models tailored to your needs.
At Pharmegic, we specialize in the research and development of small-molecule pharmaceuticals, with a strong focus on complex injectables, oral solids, oral liquids, and sterile ophthalmics. Our R&D model is built to be flexible — offering both fee-for-service support and strategic co-development partnerships.
Whether you’re a virtual biotech or a mid-sized sponsor seeking expert formulation support, Pharmegic delivers science-first, lean, and globally aligned R&D solutions.
We operate as an external R&D engine for clients who need reliable, high-quality development services without the cost of internal infrastructure. Our team supports programs from pre-formulation through exhibit batch and tech transfer.
All projects are milestone-driven, with clear timelines and transparent costing.
For select opportunities, Pharmegic engages in co-development partnerships — ideal for differentiated formulations, 505(b)(2) strategies, or repurposed assets. We provide full R&D execution while jointly structuring ownership or commercial rights.
Each co-development opportunity is assessed on strategic fit, scientific feasibility, and market potential.
